Business Description
Mydecine Innovations Group Inc
NAICS : 325411
SIC : 3741
ISIN : CA62849F2008
Compare
Compare
Traded in other countries / regions
MYCO.Canada0NF0.GermanyMYCOF.USAMYIG.UK IPO Date
2018-11-05Description
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -97.2 | |||||
| Debt-to-Equity | -0.4 | |||||
| Debt-to-EBITDA | -0.5 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 62.1 | |||||
| 3-Year EPS without NRI Growth Rate | 55.4 | |||||
| 3-Year FCF Growth Rate | 65.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.66 | |||||
| 9-Day RSI | 47.34 | |||||
| 14-Day RSI | 48.02 | |||||
| 6-1 Month Momentum % | -94.44 | |||||
| 12-1 Month Momentum % | -98.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.01 | |||||
| Quick Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -145.9 | |||||
| Shareholder Yield % | -154.64 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1137.8 | |||||
| ROIC % | -135.46 | |||||
| ROC (Joel Greenblatt) % | -408366.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.22 | |||||
| EV-to-EBITDA | -0.22 | |||||
| EV-to-Forward-Revenue | 0.74 | |||||
| EV-to-FCF | -16.03 | |||||
| Earnings Yield (Greenblatt) % | -454.55 | |||||
| FCF Yield % | -68.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mydecine Innovations Group Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.185 | ||
| Beta | 2.36 | ||
| Volatility % | 371.33 | ||
| 14-Day RSI | 48.02 | ||
| 14-Day ATR (€) | 0.001797 | ||
| 20-Day SMA (€) | 0.00245 | ||
| 12-1 Month Momentum % | -98.66 | ||
| 52-Week Range (€) | 0.001 - 0.078 | ||
| Shares Outstanding (Mil) | 61.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mydecine Innovations Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mydecine Innovations Group Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mydecine Innovations Group Inc Frequently Asked Questions
What is Mydecine Innovations Group Inc(STU:0NF0)'s stock price today?
The current price of STU:0NF0 is €0.00. The 52 week high of STU:0NF0 is €0.08 and 52 week low is €0.00.
When is next earnings date of Mydecine Innovations Group Inc(STU:0NF0)?
The next earnings date of Mydecine Innovations Group Inc(STU:0NF0) is .
Does Mydecine Innovations Group Inc(STU:0NF0) pay dividends? If so, how much?
Mydecine Innovations Group Inc(STU:0NF0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers